ClinicalTrials.gg
Active, not recruitingNCT04605016Updated May 10, 2023

Clinical Performance of Dentals Implants With Hydrophilic or Hydrophobic Surfaces

An interventional study of Hydrophilic surface implants and Hydrophobic surface implants in Tooth Loss, sponsored by Universidade Federal de Goias. Active, not recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by Universidade Federal de Goias · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 2 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to compare longitudinally the clinical performance of dental implants with different surfaces placed in single tooth gaps at the posterior maxilla and mandible of adults. It is a randomized clinical trial, in which participants will be randomly allocated to two groups: test group (implants with hydrophilic surface) and control group (implants with hydrophobic surface). The null hypothesis is that the implant stability quotient of hydrophilic and hydrophobic dental implants show a similar progression after placement in posterior tooth gaps.

02

Conditions studied

  • Tooth Loss

Browse trials for

Keywords

  • single tooth gap
  • missing tooth
03

In context

Tooth Loss

165 studies on the registry are indexed under Tooth Loss; 43 are open to participants now.

This study's enrollment of 44 is above the median of 30 across 120 interventional studies indexed under Tooth Loss.

Browse Tooth Loss studies →

Lead sponsor

Universidade Federal de Goias is the lead sponsor of 42 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Present single or multiple intercalated untreated tooth gaps in the posterior region of the mandible or maxilla;
  • Agree to participate in the study by signing the form.

Exclusion criteria

Exclusion Criteria:

  • Unavailability for participation or signs that they could not comply with the schedule of follow-up visits;
  • Presence of general and/or local that could prevent the surgical procedure for implant placement;
  • Presence of conditions that may interfere with the prognosis, such as current treatment with bisphosphonates or report of use for less than 2 years, presence of rheumatic diseases, among others;
  • Absence of the minimum bone quantity of 8 mm in length and 3.75 mm in diameter for installation of an implant in the tooth gap;
  • Absence of a mesio-distal space of at least 4.6 mm in the single tooth gap required to place the surgical guide;
  • Do not present a mouth opening of at least 12mm required for the proper of the guided surgical kit together with the surgical guide;
  • Do not present a band of keratinized tissue favorable for maintaining peri-implant health.
  • Present motor difficulties that compromise adequate oral hygiene.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Hydrophilic surface implants

    Device: Hydrophilic surface implants

  • Active comparator
    Hydrophobic surface implants

    Device: Hydrophobic surface implants

Interventions

  • DeviceHydrophilic surface implants

    A dental implant with hydrophilic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

    Also known as: Neodent Helix Grand Morse® Acqua

  • DeviceHydrophobic surface implants

    A dental implant with hydrophobic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.

    Also known as: Neodent Helix Grand Morse® Neoporos

06

What researchers measure

Primary outcomes

  1. Change of implant stability

    Implant stability was set as the primary outcome. The implant stability quotient (ISQ) will be measured using a portable device called Osstell ISQ (Osstell Mentor, Integration Diagnostics, Göteborg, Sweden).

    Time frame: 10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.

Secondary outcomes

  1. Implant success

    Each implant will be assessed according to the health scale of the International Congress of Oral Implantologists (ICOI-Pisa health scale). After clinical assessment, each implant will be classified as 'success', 'satisfactory survival', 'compromised survival' or 'failure'.

    Time frame: Assessed at the 12-month follow-up visit.

  2. Periimplant bone level

    Periapical radiographs will be obtained and the periimplant bone level will be measured and compared longitudinally.

    Time frame: Radiographs will be obtained at 4 time points: immediately after implant placement, at the session of the provisional prosthesis installation, and at the 6 and 12-month follow-up visits after the delivery of the definitive prosthesis.

  3. Condition of the periimplant soft tissues

    The following parameters will be assessed clinically: presence/absence of bleeding on probing, probing depth, and presence/absence suppuration.

    Time frame: 15-days, 6- and 12-month follow-up visits after delivery of the definitive prosthesis.

07

Study locations

1 site
  • Faculty of Dentistry of the Federal University of Goias
    Goiania, Goias, Brazil
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Sep 2023, 29 months after the start.

Of 71 non-industry interventional studies with no phase under Tooth Loss, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 29 months is close to that.

Counting every sponsor, half of 77 studies reached it within 28 months; a quarter within 12 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2020
First posted
Oct 27, 2020
StartActual
Apr 1, 2021
Primary completionEst.
Sep 11, 2023
CompletionEst.
Dec 30, 2023
Last update
May 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04605016
Lead sponsor
Universidade Federal de Goias
Responsible party
Cláudio Rodrigues Leles (Full Professor, Universidade Federal de Goias) — Principal investigator
First posted
Oct 27, 2020
Start date
Apr 1, 2021
Primary completion
Sep 11, 2023 (estimated)
Completion
Dec 30, 2023 (estimated)
Last update
May 10, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion